NCT07103018 2026-03-16
STRIKE-001
K36 Therapeutics, Inc.
Phase 1 Recruiting
Clinical Trials
15 trialsNCT06353906 2025-12-08
PRIAM
The Netherlands Cancer Institute
Phase 2 Recruiting
NCT06785636 2025-11-14
P300
Pathos AI, Inc.
Phase 1/2 Recruiting
NCT06659926 2025-07-08
The Radium-select Study
The Netherlands Cancer Institute
Phase NA Recruiting
NCT06190899 2025-03-21
Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer
Celcuity Inc
Phase 1/2 Recruiting
NCT06706921 2024-11-27
18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer
VA Greater Los Angeles Healthcare System
Phase 4 Recruiting
NCT00946881 2024-02-07
Safety and Tolerability Study Using WST11 In Patients With Localized Prostate Cancer
Steba Biotech S.A.
Phase 1/2 Completed
NCT03721029 2023-03-02
Intraoperative Nerve Monitoring During Robotic-assisted Radical Prostatectomy
Herlev and Gentofte Hospital
Phase NA Completed
NCT04225299 2020-11-13
Evaluation of Efficacy of TOOKAD® (VTP) Versus Active Surveillance for Intermediate Risk Localized Prostate Cancer
Steba Biotech S.A.
Phase 3 Withdrawn
NCT01443026 2019-11-19
The Effects of Lycopene on High Risk Prostatic Tissue
University of Illinois at Chicago
Phase 2 Completed
NCT01310894 2019-07-11
PCM301
Steba Biotech S.A.
Phase 3 Completed
NCT00744549 2018-02-14
Study of Antioxidants on MRI Detectable Early Stage Prostate Cancer Among Men on Active Surveillance
University Health Network, Toronto
Phase 2 Completed
NCT00844792 2017-10-26
Study of Antioxidants on Prostate Tumors in Men Undergoing Radical Prostatectomy for Prostate Cancer
University Health Network, Toronto
Phase 2 Completed
NCT00707356 2016-04-19
Study of WST11 in Patients With Localized Prostate Cancer
Steba Biotech S.A.
Phase 2 Completed
NCT00975429 2015-04-28
Study Using WST11 in Patients With Localized Prostate Cancer
Steba Biotech S.A.
Phase 2 Completed